Ironwood Pharmaceuticals (IRWD) Research & Development: 2010-2025
Historic Research & Development for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $22.5 million.
- Ironwood Pharmaceuticals' Research & Development fell 24.67% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 18.93%. This contributed to the annual value of $111.4 million for FY2024, which is 4.02% down from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Research & Development of $22.5 million as of Q3 2025, which was down 3.87% from $23.4 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' Research & Development's 5-year high stood at $35.7 million during Q4 2023, with a 5-year trough of $6.0 million in Q2 2023.
- Its 3-year average for Research & Development is $24.7 million, with a median of $25.8 million in 2024.
- Per our database at Business Quant, Ironwood Pharmaceuticals' Research & Development crashed by 67.20% in 2022 and then surged by 406.47% in 2024.
- Over the past 5 years, Ironwood Pharmaceuticals' Research & Development (Quarterly) stood at $31.9 million in 2021, then slumped by 67.20% to $10.4 million in 2022, then spiked by 241.53% to $35.7 million in 2023, then declined by 28.83% to $25.4 million in 2024, then declined by 24.67% to $22.5 million in 2025.
- Its last three reported values are $22.5 million in Q3 2025, $23.4 million for Q2 2025, and $27.4 million during Q1 2025.